These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7700292)

  • 21. Neuropathology of fetal nigra transplants for Parkinson's disease.
    Kordower JH; Sortwell CE
    Prog Brain Res; 2000; 127():333-44. PubMed ID: 11142034
    [No Abstract]   [Full Text] [Related]  

  • 22. [Transplantation of nigral and adrenal tissue into the striatum in rats--an experimental model for the surgical treatment of Parkinson disease].
    Novaković B; Nagulić M; Nagulić I; Mrsulja ; Vujadinović M; Pavićević M
    Srp Arh Celok Lek; 1991; 119(7-8):179-81. PubMed ID: 1792572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pig xenografts to the immunocompetent rat brain: Survival rates using distinct neurotoxic lesions in the nigrostriatal pathway and two rat strains.
    Robichon R; Jaafar A; Terqui M; Brachet P; Peschanski M
    Exp Neurol; 2005 Aug; 194(2):333-40. PubMed ID: 16022861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of neurotrophin-5 on the growth and survival of nigral grafts in a rat model of Parkinson's disease.
    Haque NS; Hlavin ML; Fawcett J; Dunnett SB
    Gene Ther; 1994; 1 Suppl 1():S60. PubMed ID: 8542406
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease.
    Björklund LM; Isacson O
    Prog Brain Res; 2002; 138():411-20. PubMed ID: 12432781
    [No Abstract]   [Full Text] [Related]  

  • 26. [Transplantation of fetal dopaminergic cells in Parkinson disease].
    Zabek M; Mazurowski W; Dymecki J; Stelmachów J; Gawur B; Trautsolt W; Zawada E
    Neurol Neurochir Pol; 1992; Suppl 1():13-9. PubMed ID: 1407286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplantation of fetal mesencephalic tissue in Parkinson's disease.
    Freed CR; Breeze RE; Schneck SA
    N Engl J Med; 1995 Sep; 333(11):730-1. PubMed ID: 7637761
    [No Abstract]   [Full Text] [Related]  

  • 28. Positive potential of fetal nigral implants for Parkinson disease.
    Landau WM
    Arch Neurol; 2004 Nov; 61(11):1808-9. PubMed ID: 15534196
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
    Törnqvist N; Björklund L; Strömberg I
    Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of solid intraventricular and dissociated intraparenchymal fetal substantia nigra grafts in a rat model of Parkinson's disease: impaired graft survival is associated with high baseline rotational behavior.
    Heim RC; Willingham G; Freed WJ
    Exp Neurol; 1993 Jul; 122(1):5-15. PubMed ID: 8101821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future perfect? Presymptomatic diagnosis, neural transplantation, and trophic factors.
    Shults CW
    Neurol Clin; 1992 May; 10(2):567-93. PubMed ID: 1584189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human ventromesencephalic grafts restore dopamine release and clearance in hemiparkinsonian rats.
    Wang Y; Lin JC; Chiou AL; Liu JY; Liu JC; Zhou FC
    Exp Neurol; 1995 Dec; 136(2):98-106. PubMed ID: 7498419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease.
    Marchionini DM; Collier TJ; Camargo M; McGuire S; Pitzer M; Sortwell CE
    J Comp Neurol; 2003 Sep; 464(2):172-9. PubMed ID: 12898610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.
    Kordower JH; Chu Y; Hauser RA; Freeman TB; Olanow CW
    Nat Med; 2008 May; 14(5):504-6. PubMed ID: 18391962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lewy body pathology in fetal grafts.
    Chu Y; Kordower JH
    Ann N Y Acad Sci; 2010 Jan; 1184():55-67. PubMed ID: 20146690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Embryonic substantia nigra grafts show directional outgrowth to cografted striatal grafts and potential for pathway reconstruction in nonhuman primate.
    Sladek JR; Bjugstad KB; Collier TJ; Bundock EA; Blanchard BC; Elsworth JD; Roth RH; Redmond DE
    Cell Transplant; 2008; 17(4):427-44. PubMed ID: 18522245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional integration of neural grafts in Parkinson's disease.
    Barker RA; Dunnett SB
    Nat Neurosci; 1999 Dec; 2(12):1047-8. PubMed ID: 10570477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A sequential intrastriatal dopaminergic graft strategy in the rodent model for Parkinson's disease: implications for graft survival and targeting.
    Baker KA; Purdy MB; Sadi D; Mukhida K; Mendez I
    Cell Transplant; 2002; 11(3):185-93. PubMed ID: 12075984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
    Yurek DM
    Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caspase inhibition reduces apoptosis and increases survival of nigral transplants.
    Schierle GS; Hansson O; Leist M; Nicotera P; Widner H; Brundin P
    Nat Med; 1999 Jan; 5(1):97-100. PubMed ID: 9883846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.